Healthcare -
Biotechnology - NASDAQ - GB
$ 2.86
-1.38 %
$ 443 M
Market Cap
-9.53
P/E
MREO - LONG-TERM DEBT
Long-term Debt MREO - Mereo BioPharma Group plc
5.3 M
LAST VALUE
73.83%
2 YEAR CAGR
-18.40%
5 YEAR CAGR
0.00%
10 YEAR CAGR